QIAGEN acquires majority stake in enzymes provider BLIRT S.A.
BLIRT adds new R&D and manufacturing capabilities for customized and standardized recombinant enzymes, as well as molecular biology reagents
12-May-2022 -
QIAGEN N.V. announced that it has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A., a manufacturer of recombinant enzymes for the life science industry based in Gdansk, Poland.
BLIRT develops, manufactures and commercializes standardized and customized solutions for ...
acquisitions
enzymes
proteins
+3